Naltrexone Augmentation of Nicotine Patch Therapy
This double blind placebo controlled study is designed to determine whether naltrexone can be used to help reduce cigarette use and craving for cigarettes. Eligible participants will receive 21mg transdermal nicotine as an outpatient. In addition, participants will receive one of three doses of naltrexone (25,50 or 100mg) or a placebo and brief counseling over the course of six weeks with follow-up appointments three, six, and twelve months after the beginning of treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
200
Substance Abuse Treatment Unit
New Haven, Connecticut, United States
VA Connecticut Health Care System
New Haven, Connecticut, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.